生物科技公司Twist Bioscience Corp（TWST）今日盘中股价大跌5.2%，引发市场关注。
导致股价下跌的主要原因是华尔街知名投行摩根大通下调了该公司的目标价。根据最新报告，摩根大通将Twist Bioscience的目标价从40美元下调至33美元，降幅达17.5%。
分析师目标价的大幅下调通常会对公司股价产生负面影响，因为这反映了分析师对公司未来前景的看法变得更加谨慎。投资者可能会根据这一新的评估来调整他们的投资决策，从而导致股价下跌。目前尚不清楚摩根大通下调目标价的具体原因，投资者应密切关注公司未来的财务表现和行业动态。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.